| Income Statement |
| Operating Expenses | 8.32M |
|
| Research and Development Expense | 5.64M |
| Selling, General and Administrative Expense | 2.68M |
| Operating Income | -8.32M |
| Net Income | -7.94M |
| Net Income Common Stock | -7.94M |
| Net Income Common Stock (USD) | -7.94M |
| Consolidated Income | -7.94M |
| Earnings per Basic Share | -0.13 |
| Earnings per Basic Share (USD) | -0.13 |
| Earnings per Diluted Share | -0.13 |
| Earning Before Interest & Taxes (EBIT) | -7.94M |
| Earning Before Interest & Taxes (USD) | -7.94M |
| Weighted Average Shares | 60.79M |
| Weighted Average Shares Diluted | 60.79M |
| Balance Sheet |
| Cash and Equivalents | 27.60M |
| Cash and Equivalents (USD) | 27.60M |
| Current Assets | 28.24M |
| Total Assets | 28.24M |
| Current Liabilities | 6.26M |
| Total Liabilities | 7.57M |
| Accumulated Retained Earnings (Deficit) | -123.94M |
| Accumulated Other Comprehensive Income | -41.69K |
| Shareholders Equity | 20.68M |
| Shareholders Equity (USD) | 20.68M |
| Assets Non-Current | 2.80K |
| Liabilities Non-Current | 1.31M |
| Trade and Non-Trade Payables | 2.84M |
| Cash Flow |
| Net Cash Flow from Financing | -65.00K |
| Net Cash Flow / Change in Cash & Cash Equivalents | -6.82M |
| Net Cash Flow from Operations | -6.75M |
| Effect of Exchange Rate Changes on Cash | -2.22K |
| Share Based Compensation | 723.92K |